Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Lucy Clare Padget has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 12, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14710620

QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR

IPC classification:
A61K 31/505, A61K 31/495, C07D 403/12
Applicant:
AstraZeneca AB
Agent:
Multiple attorneys, Kilburn & Strode LLP
Agent:
Lucy Clare Padget, AstraZeneca UK Limited
Status:
The patent has been granted

Please Sign in to use this feature